Payment overview · 2025
General Payments
$626.02
33 reported records · 9 companies
Healthcare provider profile · identity verified
Michael David Stormont, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · GALION, OH · NPI 1811221153
Verified facts
What the public records show
CMS Open Payments records show Michael David Stormont, M.D. received $626.02 in general payments during 2025 across 33 reported records.
ABBVIE INC. accounted for 46.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 12 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Kerendia, Vraylar.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 71 claims for Synthroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 39 claims for Vraylar by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 67 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Symbicort by this doctor in 2024.
Bayer Healthcare Pharmaceuticals Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Kerendia as an associated drug or biological on 138674 records involving 48458 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Kerendia by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $290.83 | 46.5% | 21 | 2025 |
| Teleflex LLC | Unresolved — no canonical attribution shown | $115.95 | 18.5% | 1 | 2025 |
| Indivior Inc. | Unresolved — no canonical attribution shown | $70.31 | 11.2% | 3 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $37.44 | 6.0% | 2 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $36.17 | 5.8% | 2 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $24.18 | 3.9% | 1 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $20.57 | 3.3% | 1 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $15.44 | 2.5% | 1 | 2025 |
| Braeburn Inc. | Unresolved — no canonical attribution shown | $15.13 | 2.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $610.03 | 32 |
| Education | $15.99 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $153.88 | 12 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $136.95 | 9 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $128.80 | 7 | 2025 |
Source payment records
|
|||||
| UROLIFT Normalized: urolift |
Device | Teleflex LLC | $115.95 | 1 | 2025 |
Source payment records
|
|||||
| SUBLOCADE Normalized: sublocade |
Drug | Indivior Inc. | $70.31 | 3 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 2 Normalized: freestyle libre 2 |
Device | Abbott Laboratories | $37.44 | 2 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $24.18 | 1 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $20.57 | 1 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $20.18 | 1 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $15.99 | 1 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $15.44 | 1 | 2025 |
Source payment records
|
|||||
| BRIXADI Normalized: brixadi |
Drug | Braeburn Inc. | $15.13 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Kerendia kerendia |
2025 | Kerendia | 2024 | 23 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| VRAYLAR vraylar |
2025 | Vraylar | 2024 | 39 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
21 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
71 | 19 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | VRAYLAR open payments reported associated product |
CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550 |
Vraylar · 2024 Exact normalized brand match · 1 Part D row |
39 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
67 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
32 | 11 |
| Bayer Healthcare Pharmaceuticals Inc. Exact reporting entity; no affiliate inference |
2025 | Kerendia open payments reported associated product |
CMS Open Payments — General Payments 138674 supporting records · 48458 recipient NPIs · example record 1225434663 |
Kerendia · 2024 Exact normalized brand match · 1 Part D row |
23 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1475 | 346 |
| Levothyroxine Sodium | Levothyroxine Sodium | 844 | 196 |
| Gabapentin | Gabapentin | 743 | 139 |
| Omeprazole | Omeprazole | 691 | 180 |
| Lisinopril | Lisinopril | 678 | 164 |
| Losartan Potassium | Losartan Potassium | 626 | 168 |
| Amlodipine Besylate | Amlodipine Besylate | 596 | 161 |
| Metformin Hcl | Metformin Hcl | 593 | 111 |
| Sertraline Hcl | Sertraline Hcl | 563 | 118 |
| Furosemide | Furosemide | 554 | 142 |
| Trazodone Hcl | Trazodone Hcl | 506 | 114 |
| Eliquis | Apixaban | 492 | 70 |
| Pantoprazole Sodium | Pantoprazole Sodium | 460 | 98 |
| Potassium Chloride | Potassium Chloride | 427 | 97 |
| Metoprolol Tartrate | Metoprolol Tartrate | 401 | 87 |
| Metoprolol Succinate | Metoprolol Succinate | 357 | 94 |
| Duloxetine Hcl | Duloxetine Hcl | 341 | 91 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 339 | 112 |
| Tamsulosin Hcl | Tamsulosin Hcl | 314 | 73 |
| Carvedilol | Carvedilol | 306 | 71 |
| Montelukast Sodium | Montelukast Sodium | 293 | 77 |
| Famotidine | Famotidine | 280 | 81 |
| Hydrochlorothiazide | Hydrochlorothiazide | 278 | 71 |
| Clopidogrel | Clopidogrel Bisulfate | 265 | 58 |
| Prednisone | Prednisone | 263 | 174 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 254 | 25 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 248 | 36 |
| Buspirone Hcl | Buspirone Hcl | 244 | 54 |
| Tramadol Hcl | Tramadol Hcl | 237 | 42 |
| Quetiapine Fumarate | Quetiapine Fumarate | 226 | 41 |
| Jardiance | Empagliflozin | 213 | 36 |
| Spironolactone | Spironolactone | 209 | 40 |
| Fluoxetine Hcl | Fluoxetine Hcl | 208 | 34 |
| Pravastatin Sodium | Pravastatin Sodium | 204 | 53 |
| Fluticasone Propionate | Fluticasone Propionate | 202 | 75 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 200 | 36 |
| Mirtazapine | Mirtazapine | 195 | 47 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 191 | 51 |
| Simvastatin | Simvastatin | 191 | 54 |
| Divalproex Sodium | Divalproex Sodium | 187 | 38 |
| Bupropion Xl | Bupropion Hcl | 183 | 55 |
| Meloxicam | Meloxicam | 179 | 56 |
| Ropinirole Hcl | Ropinirole Hcl | 170 | 35 |
| Ondansetron Odt | Ondansetron | 167 | 62 |
| Glimepiride | Glimepiride | 163 | 33 |
| Alprazolam | Alprazolam | 156 | 36 |
| Allopurinol | Allopurinol | 155 | 39 |
| Zolpidem Tartrate | Zolpidem Tartrate | 146 | 27 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 145 | 46 |
| Citalopram Hbr | Citalopram Hydrobromide | 144 | 41 |
| Donepezil Hcl | Donepezil Hcl | 143 | 30 |
| Glipizide | Glipizide | 143 | 25 |
| Lorazepam | Lorazepam | 143 | 37 |
| Baclofen | Baclofen | 135 | 24 |
| Azithromycin | Azithromycin | 132 | 114 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 128 | 42 |
| Oxycodone Hcl | Oxycodone Hcl | 127 | 17 |
| Pregabalin | Pregabalin | 126 | 14 |
| Atenolol | Atenolol | 125 | 29 |
| Olanzapine | Olanzapine | 122 | 28 |
| Tizanidine Hcl | Tizanidine Hcl | 118 | 33 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 116 | 34 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 115 | 29 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 114 | 39 |
| Nystatin | Nystatin | 108 | 63 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 104 | 32 |
| Methylprednisolone | Methylprednisolone | 101 | 80 |
| Amitriptyline Hcl | Amitriptyline Hcl | 98 | 24 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 96 | 60 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 96 | 42 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 96 | 25 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 95 | 45 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 94 | 13 |
| Warfarin Sodium | Warfarin Sodium | 93 | 22 |
| Bumetanide | Bumetanide | 92 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 91 | 25 |
| Mounjaro | Tirzepatide | 91 | 13 |
| Risperidone | Risperidone | 91 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 90 | 31 |
| Ozempic | Semaglutide | 90 | 24 |
| Sucralfate | Sucralfate | 89 | 19 |
| Memantine Hcl | Memantine Hcl | 88 | 18 |
| Sumatriptan Succinate | Sumatriptan Succinate | 87 | 19 |
| Alendronate Sodium | Alendronate Sodium | 86 | 20 |
| Ezetimibe | Ezetimibe | 85 | 21 |
| Ondansetron Hcl | Ondansetron Hcl | 84 | 42 |
| Finasteride | Finasteride | 83 | 21 |
| Aripiprazole | Aripiprazole | 82 | 13 |
| Xarelto | Rivaroxaban | 81 | 16 |
| Metformin Hcl Er | Metformin Hcl | 80 | 24 |
| Celecoxib | Celecoxib | 79 | 19 |
| Fluconazole | Fluconazole | 79 | 39 |
| Hydralazine Hcl | Hydralazine Hcl | 79 | 24 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 77 | 31 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 76 | 14 |
| Myrbetriq | Mirabegron | 75 | 12 |
| Nifedipine Er | Nifedipine | 74 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 73 | 29 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 72 | 21 |
| Meclizine Hcl | Meclizine Hcl | 71 | 21 |
| Synthroid | Levothyroxine Sodium | 71 | 19 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 68 | 19 |
| Clonidine Hcl | Clonidine Hcl | 67 | 17 |
| Farxiga | Dapagliflozin Propanediol | 67 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 67 | 14 |
| Januvia | Sitagliptin Phosphate | 66 | 14 |
| Topiramate | Topiramate | 66 | 16 |
| Cephalexin | Cephalexin | 65 | 47 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 64 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 64 | 22 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 62 | 28 |
| Pioglitazone Hcl | Pioglitazone Hcl | 61 | 14 |
| Clonazepam | Clonazepam | 59 | suppressed |
| Zubsolv | Buprenorphine Hcl/Naloxone Hcl | 58 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 54 | 32 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 53 | 18 |
| Levetiracetam | Levetiracetam | 53 | 11 |
| Valacyclovir | Valacyclovir Hcl | 53 | 22 |
| Albuterol Sulfate | Albuterol Sulfate | 49 | 16 |
| Buprenorphine Hcl | Buprenorphine Hcl | 48 | suppressed |
| Lamotrigine | Lamotrigine | 48 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 47 | 12 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 46 | 46 |
| Latanoprost | Latanoprost | 46 | 14 |
| Ibuprofen | Ibuprofen | 45 | 21 |
| Midodrine Hcl | Midodrine Hcl | 45 | 15 |
| Belbuca | Buprenorphine Hcl | 44 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 44 | suppressed |
| Novolin R | Insulin Regular, Human | 43 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 42 | 16 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 42 | 15 |
| Trulicity | Dulaglutide | 41 | 12 |
| Dicyclomine Hcl | Dicyclomine Hcl | 40 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 40 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 40 | 29 |
| Vraylar | Cariprazine Hcl | 39 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 38 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 38 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 38 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 36 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 36 | 16 |
| Ziprasidone Hcl | Ziprasidone Hcl | 36 | suppressed |
| Chlorthalidone | Chlorthalidone | 35 | suppressed |
| Naproxen | Naproxen | 35 | 15 |
| Primidone | Primidone | 35 | suppressed |
| Hydrocortisone | Hydrocortisone | 33 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 32 | 12 |
| Fenofibrate | Fenofibrate | 32 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 32 | suppressed |
| Lactulose | Lactulose | 32 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 32 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 32 | 11 |
| Haloperidol | Haloperidol | 31 | suppressed |
| Valsartan | Valsartan | 31 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 30 | 13 |
| Rifampin | Rifampin | 30 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 29 | 17 |
| Digoxin | Digoxin | 29 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 29 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 29 | suppressed |
| Levofloxacin | Levofloxacin | 29 | 20 |
| Amiodarone Hcl | Amiodarone Hcl | 28 | suppressed |
| Colchicine | Colchicine | 28 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 28 | suppressed |
| Temazepam | Temazepam | 28 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 27 | 16 |
| Humalog Kwikpen U-100 | Insulin Lispro | 27 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 27 | 15 |
| Nitroglycerin | Nitroglycerin | 27 | 21 |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 27 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 20 |
| Ertapenem | Ertapenem Sodium | 26 | 13 |
| Glucagon Emergency Kit | Glucagon | 26 | 19 |
| Insulin Lispro | Insulin Lispro | 26 | suppressed |
| Mupirocin | Mupirocin | 26 | 12 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 25 | 11 |
| Ceftriaxone | Ceftriaxone In Is-Osm Dextrose | 25 | suppressed |
| Lansoprazole | Lansoprazole | 25 | suppressed |
| Loperamide | Loperamide Hcl | 25 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 25 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 25 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 24 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 24 | suppressed |
| Lovastatin | Lovastatin | 24 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 24 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 23 | suppressed |
| Fentanyl | Fentanyl | 23 | suppressed |
| Kerendia | Finerenone | 23 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 23 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 23 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 22 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 22 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 22 | 13 |
| Austedo Xr | Deutetrabenazine | 21 | suppressed |
| Carbamazepine Er | Carbamazepine | 21 | suppressed |
| Cilostazol | Cilostazol | 21 | suppressed |
| Linzess | Linaclotide | 21 | suppressed |
| Acyclovir | Acyclovir | 20 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 20 | suppressed |
| Methotrexate | Methotrexate Sodium | 20 | suppressed |
| Metolazone | Metolazone | 20 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 20 | suppressed |
| Verapamil Er | Verapamil Hcl | 20 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 19 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 19 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 19 | suppressed |
| Klor-Con M20 | Potassium Chloride | 19 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 19 | suppressed |
| Ramipril | Ramipril | 19 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 19 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 19 | suppressed |
| Gemfibrozil | Gemfibrozil | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 18 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | suppressed |
| Amoxicillin | Amoxicillin | 17 | 16 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 17 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Entresto | Sacubitril/Valsartan | 17 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 17 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 17 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 17 | suppressed |
| Ranolazine Er | Ranolazine | 17 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 17 | suppressed |
| Tradjenta | Linagliptin | 17 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Nabumetone | Nabumetone | 16 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 16 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 16 | 11 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 15 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 15 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 15 | suppressed |
| Klayesta | Nystatin | 15 | suppressed |
| Lidocaine | Lidocaine | 15 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 15 | suppressed |
| Rivastigmine | Rivastigmine | 15 | suppressed |
| Telmisartan | Telmisartan | 15 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 14 | suppressed |
| Calcium Acetate | Calcium Acetate | 14 | suppressed |
| Diazepam | Diazepam | 14 | suppressed |
| Dofetilide | Dofetilide | 14 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 14 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 14 | suppressed |
| Torsemide | Torsemide | 14 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 14 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Gvoke Pfs 1-Pack Syringe | Glucagon | 13 | suppressed |
| Ingrezza | Valbenazine Tosylate | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Roflumilast | Roflumilast | 13 | suppressed |
| Scopolamine | Scopolamine | 13 | suppressed |
| Tirosint | Levothyroxine Sodium | 13 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Humulin R | Insulin Regular, Human | 12 | suppressed |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine Dimesylate | 12 | suppressed |
| Methocarbamol | Methocarbamol | 12 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 12 | 12 |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Perphenazine | Perphenazine | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Vascepa | Icosapent Ethyl | 12 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 12 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 11 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 11 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Nateglinide | Nateglinide | 11 | suppressed |
| Nystop | Nystatin | 11 | suppressed |
| Tetrabenazine | Tetrabenazine | 11 | suppressed |
| Timolol Maleate | Timolol Maleate | 11 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
| Vyzulta | Latanoprostene Bunod | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $626.02 · 33 records | ABBVIE INC. | AIRSUPRA, Auvelity, BREZTRI, BRIXADI, FREESTYLE LIBRE 2, Kerendia, QULIPTA, REXULTI, SUBLOCADE, UBRELVY, UROLIFT, VRAYLAR | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Kerendia play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error